Related Experiment Video
Updated: Sep 24, 2025
Vessel-Sparing Microsurgical Longitudinal Intussusception Vasoepididymostomy to Treat Epididymal Obstructive Azoospermia
Published on: May 27, 2022
Identification of pathogenic mutations from nonobstructive azoospermia patients†
Hanwei Jiang1, Yuanwei Zhang1, Hui Ma1
1Division of Reproduction and Genetics, First Affiliated Hospital of USTC, School of Basic Medical Sciences, Division of Life Sciences and Medicine, Hefei National Research Center for Physical Sciences at the Microscale, Biomedical Sciences and Health Laboratory of Anhui Province, University of Science and Technology of China, Hefei, China.
Genetic anomalies cause 25% of nonobstructive azoospermia (NOA) cases. Advances in whole exome sequencing and CRISPR-Cas9 improve the identification and verification of pathogenic mutations in male infertility research.
Area of Science:
- Genetics
- Reproductive Biology
- Human Infertility
Background:
- Approximately 25% of nonobstructive azoospermia (NOA) cases stem from genetic anomalies.
- Despite extensive research, only 14 pathogenic mutations have been identified in NOA patients, highlighting a gap in current knowledge.
- The limited number of identified mutations suggests a need for improved screening and verification methodologies.
Purpose of the Study:
- To review identified pathogenic mutations in NOA patients.
- To discuss advancements in mutation screening and functional verification techniques.
- To highlight the impact of new technologies on understanding the genetic etiology of male infertility.
Main Methods:
- Review of existing literature on genetic mutations in nonobstructive azoospermia.
- Discussion of technological advancements including whole exome sequencing.
- Exploration of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 applications in genetic research.
Main Results:
- Summary of known pathogenic mutations contributing to NOA.
- Demonstration of how advanced technologies enhance mutation detection efficiency.
- Evidence of improved functional verification methods for identified genes.
Conclusions:
- New technologies like whole exome sequencing and CRISPR-Cas9 are crucial for advancing the study of male infertility.
- Further research is needed to identify more genetic causes of NOA and improve diagnostic capabilities.
- Enhanced methodologies will accelerate the discovery of genetic factors underlying human infertility.
